Medline Inc. L10
| 09/26/2026 | 06/27/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.23% | 4.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.23% | 4.53% | |||
| Cost of Revenue | 3.43% | 5.28% | |||
| Gross Profit | -1.49% | 2.28% | |||
| SG&A Expenses | -2.78% | 5.46% | |||
| Depreciation & Amortization | -0.56% | 0.57% | |||
| Other Operating Expenses | -16.67% | -20.00% | |||
| Total Operating Expenses | 2.20% | 5.14% | |||
| Operating Income | 2.76% | -5.45% | |||
| Income Before Tax | 64.26% | -19.24% | |||
| Income Tax Expenses | -29.17% | 84.62% | |||
| Earnings from Continuing Operations | 128.78% | -41.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -55.70% | 28.18% | |||
| Net Income | 225.00% | -53.49% | |||
| EBIT | 2.76% | -5.45% | |||
| EBITDA | 2.14% | -3.11% | |||
| EPS Basic | 251.87% | -61.85% | |||
| Normalized Basic EPS | -13.89% | -6.39% | |||
| EPS Diluted | 240.81% | -60.37% | |||
| Normalized Diluted EPS | -42.35% | -6.20% | |||
| Average Basic Shares Outstanding | 2.27% | 4.52% | |||
| Average Diluted Shares Outstanding | 52.91% | 4.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||